Modeling the probability of hiv infection over time in high-risk seronegative participants receiving placebo in five randomized double-blind placebo-controlled hiv pre-exposure prophylaxis trials: a patient-level pooled analysis

HIGHLIGHTS

• who: Maria Garcia-Cremades and collaborators from the Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA, USA have published the research: Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled Analysis, in the Journal: Pharmaceutics 2022, 14, 1801. of /2022/
• what: The aim of this analysis is to quantify the individual risk of HIV infection over time using a large database of high-risk individuals (n = 5583 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.